Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris W D Armstrong

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Protocols for Studies on Genetically Engineered Mouse Models in Prostate CancerChris W D Armstrong, Oksana Lyubomska, Melissa J LaBonte, et al.
Cell Death & Disease|October 24, 2018
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonistsChristopher McCann, Nyree Crawford, Joanna Majkut, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Molecular Cancer|August 12, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathwayJan Pencik, Cecile Philippe, Michaela Schlederer, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 23, 2018
Protocols for Studies on Genetically Engineered Mouse Models in Prostate CancerChris W D Armstrong, Oksana Lyubomska, Melissa J LaBonte, et al.
Cell Death & Disease|October 24, 2018
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonistsChristopher McCann, Nyree Crawford, Joanna Majkut, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
NAR Cancer|August 4, 2020
Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinomaChris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, et al.
Molecular Cancer|August 12, 2023
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathwayJan Pencik, Cecile Philippe, Michaela Schlederer, et al.
Pageof 1